April 16, 2018 07:55 AM EDT
Publisher's note
China

End­points' Chi­na cov­er­age is get­ting deep­er. An­nounc­ing our part­ner­ship with Pharm­Cube, the lead­ing Chi­nese bio­phar­ma da­ta provider

Arsalan Arif

Founder

Our mis­sion at End­points News is to pro­vide read­ers a com­plete pic­ture of the top drug de­vel­op­ment news of the day. And in­creas­ing­ly that means …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

TRENDING NOW

Up­dat­ed: White House threat­ens ‘most fa­vored na­tion’ plan to low­er US drug prices, but many ques­tions re­main

Phar­ma in­vestors brush off Trump’s ‘most fa­vored na­tion’ plan as stocks rise

Watch Post-Hoc Live: Trump's 'most fa­vored na­tion' plan to cut drug prices

GSK to pay $1.2B up­front to snag Boston Phar­ma’s mid-stage MASH hope

Bris­tol My­ers CEO says Amer­i­ca’s bio­phar­ma pole po­si­tion is not guar­an­teed

It's been three months with­out a biotech IPO

A service from the Financial Times